FDA NDC Directory · JSON-LD · Markdown

Talzenna

NDC 0069-0252 · HUMAN PRESCRIPTION DRUG · CAPSULE, LIQUID FILLED

Generic nametalazoparib
Labeler / ManufacturerPfizer Laboratories Div Pfizer Inc
Marketing categoryNew Drug Application (innovator) · App NDA217439
Dosage form / routeCAPSULE, LIQUID FILLED · ORAL
Active ingredientsTALAZOPARIB TOSYLATE (.1 mg/1)
Marketing started20240417
Package count1

External sources

Source: openFDA. Public-domain (CC0).